Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romilda Cardin

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Biomedicines|August 27, 2021
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationFilippo Pelizzaro, Romilda Cardin, Anna Sartori, et al.
Clinical and Experimental Medicine|March 26, 2021
Circulating prostaglandin E<sub>2</sub>: a novel potential prognostic biomarker in patients with hepatocellular carcinomaFilippo Pelizzaro, Maria Piera Kitenge, Romilda Cardin, et al.
World Journal of Gastroenterology|November 1, 2011
Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitisMichela Barollo, Valentina Medici, Renata D'Incà, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 27, 2015
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesisMarika Piciocchi, Romilda Cardin, Umberto Cillo, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
Biomarkers in Medicine|August 19, 2020
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differencesFilippo Pelizzaro, Federica Soldà, Romilda Cardin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2023
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolizationElisa Pinto, Filippo Pelizzaro, Romilda Cardin, et al.
World Journal of Gastroenterology|April 4, 2014
Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathwayRomilda Cardin, Marika Piciocchi, Marina Bortolami, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Journal of Clinical Gastroenterology|April 20, 2017
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III StudyGemma Maddalo, Matteo Fassan, Romilda Cardin, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biomedicines|August 27, 2021
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationFilippo Pelizzaro, Romilda Cardin, Anna Sartori, et al.
Clinical and Experimental Medicine|March 26, 2021
Circulating prostaglandin E<sub>2</sub>: a novel potential prognostic biomarker in patients with hepatocellular carcinomaFilippo Pelizzaro, Maria Piera Kitenge, Romilda Cardin, et al.
World Journal of Gastroenterology|November 1, 2011
Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitisMichela Barollo, Valentina Medici, Renata D'Incà, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 27, 2015
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesisMarika Piciocchi, Romilda Cardin, Umberto Cillo, et al.
The American Journal of Gastroenterology|January 8, 2008
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAdriana Sergio, Chiara Cristofori, Romilda Cardin, et al.
Biomarkers in Medicine|August 19, 2020
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differencesFilippo Pelizzaro, Federica Soldà, Romilda Cardin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 2, 2023
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolizationElisa Pinto, Filippo Pelizzaro, Romilda Cardin, et al.
World Journal of Gastroenterology|April 4, 2014
Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathwayRomilda Cardin, Marika Piciocchi, Marina Bortolami, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2025
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?Sonia Facchin, Erica Bonazzi, Antonietta Tomasulo, et al.
Journal of Clinical Gastroenterology|April 20, 2017
Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III StudyGemma Maddalo, Matteo Fassan, Romilda Cardin, et al.
Pageof 6